These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 10210226
21. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, Callahan RJ, Barrow SA, Graham W, Meltzer PC, Hanson RN, Madras BK. Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103 [Abstract] [Full Text] [Related]
22. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT. Booij J, Hemelaar TG, Speelman JD, de Bruin K, Janssen AG, van Royen EA. J Nucl Med; 1999 May; 40(5):753-61. PubMed ID: 10319746 [Abstract] [Full Text] [Related]
23. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA. J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575 [Abstract] [Full Text] [Related]
24. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. Huang WS, Lin SZ, Lin JC, Wey SP, Ting G, Liu RS. J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717 [Abstract] [Full Text] [Related]
25. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain. Tsukada H, Harada N, Nishiyama S, Ohba H, Kakiuchi T. J Neurosci; 2000 Sep 15; 20(18):7067-73. PubMed ID: 10995853 [Abstract] [Full Text] [Related]
26. Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT. Bonab AA, Fischman AJ, Alpert NM. J Nucl Med; 2000 Jun 15; 41(6):1086-92. PubMed ID: 10855640 [Abstract] [Full Text] [Related]
27. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Eur J Nucl Med; 1998 Jan 15; 25(1):24-30. PubMed ID: 9396871 [Abstract] [Full Text] [Related]
28. [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome. Hwang WJ, Yao WJ, Fu YK, Yang AS. Psychiatry Res; 2008 Feb 28; 162(2):159-66. PubMed ID: 18248965 [Abstract] [Full Text] [Related]
29. Simultaneous [99mTc]TRODAT-1 and [123I]ADAM brain SPECT in nonhuman primates. Ma KH, Lee JK, Huang SY, Yeh CB, Shen YC, Shen LH, Chen CC, Liu RS, Liu JC, Huang WS. Mol Imaging Biol; 2009 Feb 28; 11(4):253-62. PubMed ID: 19225845 [Abstract] [Full Text] [Related]
30. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys. Fischman AJ, Babich JW, Elmaleh DR, Barrow SA, Meltzer P, Hanson RN, Madras BK. J Nucl Med; 1997 Jan 28; 38(1):144-50. PubMed ID: 8998169 [Abstract] [Full Text] [Related]
31. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Kung MP, Stevenson DA, Plössl K, Meegalla SK, Beckwith A, Essman WD, Mu M, Lucki I, Kung HF. Eur J Nucl Med; 1997 Apr 28; 24(4):372-80. PubMed ID: 9096087 [Abstract] [Full Text] [Related]
32. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbäumer K, Kung HF, Hahn K, Tatsch K. Eur J Nucl Med; 2000 Oct 28; 27(10):1518-24. PubMed ID: 11083541 [Abstract] [Full Text] [Related]
33. Tc-99m-labeled tropanes as dopamine transporter imaging agents. Meegalla S, Plössl K, Kung MP, Chumpradit S, Stevenson DA, Frederick D, Kung HF. Bioconjug Chem; 1996 Oct 28; 7(4):421-9. PubMed ID: 8853455 [Abstract] [Full Text] [Related]
34. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Brain; 2000 Jun 28; 123 ( Pt 6)():1155-60. PubMed ID: 10825354 [Abstract] [Full Text] [Related]
35. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters. Seibyl JP, Laruelle M, van Dyck CH, Wallace E, Baldwin RM, Zoghbi S, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB. J Nucl Med; 1996 Feb 28; 37(2):222-8. PubMed ID: 8667048 [Abstract] [Full Text] [Related]
36. Decreased dopamine transporter binding in Machado-Joseph disease. Yen TC, Lu CS, Tzen KY, Wey SP, Chou YH, Weng YH, Kao PF, Ting G. J Nucl Med; 2000 Jun 28; 41(6):994-8. PubMed ID: 10855623 [Abstract] [Full Text] [Related]
37. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy. Knudsen GM, Karlsborg M, Thomsen G, Krabbe K, Regeur L, Nygaard T, Videbaek C, Werdelin L. Eur J Nucl Med Mol Imaging; 2004 Dec 28; 31(12):1631-8. PubMed ID: 15583914 [Abstract] [Full Text] [Related]
40. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT. Naumann M, Pirker W, Reiners K, Lange KW, Becker G, Brücke T. Mov Disord; 1998 Mar 28; 13(2):319-23. PubMed ID: 9539347 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]